Stage III Bladder Cancer AJCC v8 Recruiting Phase 2 Trials for Interleukin-7 (DB11997)

IndicationStatusPhase
DBCOND0109731 (Stage III Bladder Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03513952Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial CarcinomaTreatment